Skip to main content

Secondary Navigation

  • Our Products
    • Approved Therapy
    • Product Replacement
  • Investors
    • Financials
    • Investor Resources
  • News
  • Contact Us
Home

Primary navigation

  • Our Company
    • What We Do
    • A Story of Transformation
    • Partnerships
  • Our Science
    • Therapeutic Focus Areas
    • Technologies and Platforms
    • Pipeline
    • Medical Affairs
  • Patients
    • Our Commitment
    • Patient Advocacy
    • Clinical Studies
    • Resources
  • Our People
    • Executive Leadership
    • Board of Directors
    • Committee Membership
    • Careers

News and Events

news-bi
news-si
  • All
  • Events
  • Press Releases
event-19092020
September 19, 2020

Immunomedics ESMO 2020 Update Call

press release
September 19, 2020

Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvyᵀᴹ in Metastatic Urothelial Cancer

press release
September 19, 2020

Trodelvyᵀᴹ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer

press release
September 18, 2020

Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers

press releases
September 9, 2020

Immunomedics Announces Key Oral Presentations at ESMO 2020

press releases
September 2, 2020

Immunomedics to Participate in Upcoming Healthcare Conferences

press releases
August 17, 2020

Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer of Trodelvyᵀᴹ

Press releases
August 5, 2020

Immunomedics Announces Second Quarter 2020 Results and Provides Corporate Update

press releases
July 27, 2020

Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020

press releases
July 6, 2020

Immunomedics to Host Conference Call and Webcast on July 6, 2020 to Provide Clinical Update

press releases
July 6, 2020

Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVYᵀᴹ

press releases
May 28, 2020

Immunomedics to Participate in Upcoming Healthcare Conferences

press releases
May 27, 2020

Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19

press releases
May 13, 2020

Immunomedics to Present New Trodelvy Data in Non-Breast Indications at the 2020 ASCO Virtual Meeting

press releases
May 7, 2020

Immunomedics to Participate in BofA Securities 2020 Healthcare Conference

press release
May 6, 2020

Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update

press release
May 1, 2020

Immunomedics Announces Closing of Public Offering of Common Stock

press release
April 30, 2020

Immunomedics to Report First Quarter 2020 Results and Host Conference Call and Webcast on May 6, 2020

press releases
April 28, 2020

Immunomedics Announces Pricing of Public Offering of Common Stock

press releases
April 27, 2020

Immunomedics Announces Proposed Public Offering of Common Stock

press releases
April 22, 2020

FDA Grants Accelerated Approval for Immunomedics’ Trodelvy in Previously-Treated Metastatic Triple Negative Breast Cancer

press releases
April 7, 2020

FDA Grants Fast Track Designation to Sacituzumab Govitecan for Metastatic Urothelial Cancer

press releases
April 6, 2020

Immunomedics Announces Executive Leadership Changes and the Appointment of Harout Semerjian as President and CEO

press releases
April 6, 2020

Immunomedics Announces ASCENT Study to be Stopped for Compelling Efficacy

press releases
April 3, 2020

Immunomedics to Host Conference Call and Webcast on April 06, 2020 to Provide Clinical and Corporate Update

press releases
March 25, 2020

Immunomedics Provides COVID-19 Business Continuity Update, Affirms Strategic Priorities, and Shares R&D and Regulatory Update

press releases
February 27, 2020

Immunomedics Reports Fourth Quarter and Full Year 2019 Results and Provides Corporate Update

press realeases
February 27, 2020

Immunomedics Appoints Robert W. Azelby to Board of Directors

press releases
February 25, 2020

Immunomedics to Participate in Upcoming Healthcare Conferences

press releases
February 20, 2020

Immunomedics to Report Results for the Fourth Quarter and Full Year 2019 and Host Conference Call and Webcast on February 27, 2020

press releases
February 14, 2020

Immunomedics Appoints Dr.Loretta Itri Chief Medical Officer

press releases
February 6, 2020

Immunomedics to Participate in Guggenheim Healthcare Talks | Oncology Day

Footer

  • Our Company
  • Patients
  • Our People
  • Our Products
  • News
  • Careers
  • Our Science
  • Investors
  • Contact Us
  • Partnerships
©Immunomedics

Legal Menu

  • Internet Policy
  • Legal Statement